Skip to main content
Caplight Logo









BIOPIX-T

BIOPIX-T

Private
HeraklionHealthcare & Life Scienceshttps://biopix-t.com/

Last Round

Debt

Jun 7, 2023

Total Funding Raised

$4.63M

Company Overview

BIOPIX-T is a diagnostic equipment company that develops novel portable molecular devices designed for point-of-care diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Environmental Monitoring, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

point of care testingmolecular diagnosticsPOC testinghandheld diagnosticsrapid diagnosticsinfectious disease testingLAMP testingnucleic acid amplificationlab on a chipmedical devicesfood safety testingenvironmental monitoringrazor and blades modelCOVID-19 testingdiagnostic assay development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIOPIX-T Comparables

Compare BIOPIX-T with similar companies based on industry and business-model similarity.

BIOPIX-T comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantuMDx
83%
ProtonDx
83%
Alveo Technologies
80%

BIOPIX-T Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 7, 2023
SeedApr 7, 2021
GrantSep 2, 2020
GrantNov 1, 2018

Key People

Founding team and executive leadership

George Papadakis

Co-founder & Chief Executive Officer

Founding Team

KONSTANTINOS CHATZAKIS

Chief Financial Officer

Executive Team

BIOPIX-T Investors

Notable investors and investment history

BIOPIX-T investors
InvestorRounds
Patras Science ParkGrant
Eleven VenturesDebt, Seed
SeedBlinkDebt
MetavallonDebt, Seed
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Grew 20% QoQ, from 15 to 18 employees.

  • May 4, 2025

    Monthly visitors grew 279% MoM, reaching 2K.

BIOPIX-T Filings

Explore SEC and related filing metadata, where available.

BIOPIX-T filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BIOPIX-T's valuation, stock price, and market status.

Is BIOPIX-T a public or private company?

BIOPIX-T is a private company.

What is the current stock price of BIOPIX-T?

BIOPIX-T is a private company with no public stock price. No recent secondary market data is available.

How much is BIOPIX-T worth (valuation)?

Valuation information for BIOPIX-T is not publicly available.

Can I buy BIOPIX-T stock?

BIOPIX-T shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BIOPIX-T's last funding round?

BIOPIX-T's most recent funding round was Debt on June 7, 2023.

Who are the main investors in BIOPIX-T?

Key investors in BIOPIX-T include SeedBlink.

Will BIOPIX-T IPO soon?

No public IPO plans have been announced for BIOPIX-T.

How can I track BIOPIX-T secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIOPIX-T's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHeraklion
Employee Range18
Year Founded2019
Last FundingJun 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?